BMY
Bristol-Myers Squibb·NYSE
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-03-25
Latest data update time: Updated on 2026-03-25
6.00 / 10Overall Score
NeturalInvestment Rating
6.00 / 10Overall Score
NeturalInvestment Rating
Is BMY a Buy, Sell, or Hold?
- Based on a composite score of 6.00/10, we rate BMY as a Netural. Our analysis breaks down into 6.33/10 for Fundamentals, 5.06/10 for Technicals, and 6.29/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Technical Analysis of BMY?
Is BMY undervalued or overvalued?
What is the analyst consensus for BMY?
Is BMY a Buy, Sell, or Hold?
- Based on a composite score of 6.00/10, we rate BMY as a Netural. Our analysis breaks down into 6.33/10 for Fundamentals, 5.06/10 for Technicals, and 6.29/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is BMY undervalued or overvalued?
Technical Analysis of BMY?
What is the analyst consensus for BMY?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
